Pharmaceutical Technology Europe, Sep 1, 2009 - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Pharmaceutical Technology Europe, Sep 1, 2009
Formulation
The combination drugs debate: Incompatibility problems can be overcome
By Rajesh Dubey , Avvaru Seshasayana , Satti Phanikumar Reddy , Suryakumar Jayanthi
Combining drugs with synergistic mechanisms of action yields some indisputable benefits; improved efficacy, reduced dosing, enhanced patient compliance, to name just a few.
The combination drugs debate: unstable and unpatentable
By Malcolm Ross
Combination products have been researched and administered for many years, some successfully and others not.
Is another ODT excipient necessary?
By H. Leonhard Ohrem , Roberto Ognibene
Parteck ODT is a newly introduced ready-to-use excipient for fast melt tablets.
The influence of superdisintegrant choice on the rate of drug dissolution
By Jagdish Balasubramaniam , Tim Bee
The addition of superdisintegrants to oral solid dosage forms can improve disintegration and, in turn, drug dissolution.
Regulatory
Embryonic stem cells: the moral dilemma of patentability and funding
By Beatriz San Martin
Human embryonic stem cells are of immense interest to researchers because of their ability to potentially develop into any kind of tissue.
Validation
The benefits of risk-based analyses during system validation
By Peter Woods , David Beale
When validating automated systems from third-party providers, using the V model and failure modes effects and criticality analysis (FMECA) early in the process can help.
Special Report
Belgium: Will its enviable geographic position continue to ensure success in pharma?
By Miyese Ozcan , Sam Joll , Mark Storry
Belgium is one of the largest centres for pharmaceutical distribution and has the second highest number of pharma exports per capita worldwide.
Business
What to consider when expanding businesses into North America
By William C. Cairns , Gail Steckler
Increase your chances of success in the biggest market in the world.
Ask the Expert
Successful packaging of aseptically prefilled products
By Paul Nelles
Why correctly calibrating a drug with its packaging is the key to success.
Outsourcing Review
Expansion plan
By Jim Miller
In the current slow growth environment, service providers are looking to tactical expansions, as well as more ambitious strategic service expansions.
News
News
A round up of news from across the globe.
Editor's Comment
Strength in numbers
By Fedra Pavlou
Merger, union, alliance, partnership, collaboration: five words that ultimately suggest the strengthening of something.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
30%
Oversee medical treatment of patients in the US.
9%
Provide treatment for patients globally.
8%
All of the above.
45%
No government involvement in patient treatment or drug development.
8%
Jim Miller Outsourcing Outlook Jim MillerCMO Industry Thins Out
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerFluorination Remains Key Challenge in API Synthesis
Marilyn E. Morris Guest EditorialMarilyn E. MorrisBolstering Graduate Education and Research Programs
Jill Wechsler Regulatory Watch Jill Wechsler Biopharma Manufacturers Respond to Ebola Crisis
Sean Milmo European Regulatory WatchSean MilmoHarmonizing Marketing Approval of Generic Drugs in Europe
Click here